BioLight Life Sciences (XTAE:BOLT) FCF Margin % : -4,671.43% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is BioLight Life Sciences FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BioLight Life Sciences's Free Cash Flow for the six months ended in Dec. 2023 was ₪-3.92 Mil. BioLight Life Sciences's Revenue for the six months ended in Dec. 2023 was ₪0.08 Mil. Therefore, BioLight Life Sciences's FCF Margin % for the quarter that ended in Dec. 2023 was -4,671.43%.

As of today, BioLight Life Sciences's current FCF Yield % is -60.52%.

The historical rank and industry rank for BioLight Life Sciences's FCF Margin % or its related term are showing as below:

XTAE:BOLT' s FCF Margin % Range Over the Past 10 Years
Min: -366400 Med: -2910.63 Max: -679.3
Current: -9008.47

During the past 12 years, the highest FCF Margin % of BioLight Life Sciences was -679.30%. The lowest was -366400.00%. And the median was -2910.63%.

XTAE:BOLT's FCF Margin % is ranked worse than
91.32% of 1037 companies
in the Biotechnology industry
Industry Median: -147.18 vs XTAE:BOLT: -9008.47

BioLight Life Sciences FCF Margin % Historical Data

The historical data trend for BioLight Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLight Life Sciences FCF Margin % Chart

BioLight Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-43,529.03

-366,400.00

-15,193.65

-9,008.47

BioLight Life Sciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-534,000.00	-87,033.33	-7,631.58	-19,723.53	-4,671.43

Competitive Comparison of BioLight Life Sciences's FCF Margin %

For the Biotechnology subindustry, BioLight Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioLight Life Sciences's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLight Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BioLight Life Sciences's FCF Margin % falls into.

BioLight Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BioLight Life Sciences's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-10.63	/	0.118
	=	-9,008.47 %

BioLight Life Sciences's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-3.924	/	0.084
	=	-4,671.43 %

BioLight Life Sciences FCF Margin % Related Terms

Thank you for viewing the detailed overview of BioLight Life Sciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLight Life Sciences (XTAE:BOLT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (XTAE:BOLT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kiryat Atidim, Building 7, Entrance 1, 2nd Floor, Tel-Aviv, ISR, 6158101

Website

http://www.bio-light.co.il

BioLight Life Sciences Ltd is an emerging global ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.